SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-22-019680
Filing Date
2022-05-12
Accepted
2022-05-12 08:15:31
Documents
14
Period of Report
2022-05-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K apvo-8k_20220512.htm   iXBRL 8-K 35649
2 EX-99.1 apvo-ex991_6.htm EX-99.1 219066
3 GRAPHIC g0ogcju4qkha000001.jpg GRAPHIC 2804
  Complete submission text file 0001564590-22-019680.txt   402608

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA apvo-20220512.xsd EX-101.SCH 5733
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE apvo-20220512_lab.xml EX-101.LAB 19431
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE apvo-20220512_pre.xml EX-101.PRE 11612
8 EXTRACTED XBRL INSTANCE DOCUMENT apvo-8k_20220512_htm.xml XML 3539
Mailing Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121
Business Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121 206-838-0500
Aptevo Therapeutics Inc. (Filer) CIK: 0001671584 (see all company filings)

IRS No.: 811567056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37746 | Film No.: 22915801
SIC: 2834 Pharmaceutical Preparations